This is the preview version of the Wisconsin State Legislature site.
Please see http://docs.legis.wisconsin.gov for the production version.
AB1-SSA1,21,2218 (b) A health care provider who practices within the scope of a temporary
19credential granted under this section has all rights and is subject to all
20responsibilities, malpractice insurance requirements, limitations on scope of
21practice, and other provisions that apply under chs. 440 to 480 to the practice of the
22health care provider.
AB1-SSA1,21,2523 (c) 1. A temporary credential granted under this section becomes effective on
24the date identified in the attestation under par. (a) 1. a. that the health care provider
25first provided health care services in this state under this section.
AB1-SSA1,22,4
12. a. Except as provided in subd. 2. b., a temporary credential granted under
2this section expires on the date that the department, or an examining board in the
3department, as applicable, grants or denies the application under par. (a) 1. d. for a
4permanent credential submitted by the health care provider.
AB1-SSA1,22,95 b. If a health care provider provides health care services only during the period
6covered by a national emergency declared by the U.S. president under 50 USC 1621
7in response to the 2019 novel coronavirus or during the 30 days immediately after
8the national emergency ends, a temporary credential granted under this section to
9the health care provider expires 30 days after the national emergency ends.
AB1-SSA1,22,12 10(3) Telehealth. A health care provider who practices within the scope of a
11temporary credential granted under this section may provide services through
12telehealth to a patient located in this state.
AB1-SSA1,22 13Section 22 . 440.15 of the statutes is amended to read:
AB1-SSA1,22,18 14440.15 No fingerprinting. Except as provided under ss. 440.03 (13) (c),
15441.51 (5) (a) 5., 448.980 (5) (b) 3., and 448.985 (3) (a) 4., 450.071 (3) (c) 9., and 450.075
16(3) (c) 9.,
the department or a credentialing board may not require that an applicant
17for a credential or a credential holder be fingerprinted or submit fingerprints in
18connection with the department's or the credentialing board's credentialing.
AB1-SSA1,23 19Section 23 . 450.01 (11m) of the statutes is amended to read:
AB1-SSA1,22,2220 450.01 (11m) “Facility" means a location where a wholesale distributor or
213rd-party logistics provider
stores, distributes, handles, repackages, or offers for
22sale
other services related to prescription drugs.
AB1-SSA1,24 23Section 24 . 450.01 (13w) of the statutes is created to read:
AB1-SSA1,23,424 450.01 (13w) “Out-of-state 3rd-party logistics provider” means a person
25located outside this state that contracts with a prescription drug manufacturer to

1provide or coordinate warehousing, distribution, or other services within this state
2on behalf of the manufacturer but that does not take title to the manufacturer's
3prescription drug or have general responsibility to direct the prescription drug's sale
4or disposition.
AB1-SSA1,25 5Section 25 . 450.01 (21s) of the statutes is amended to read:
AB1-SSA1,23,106 450.01 (21s)Third party Third-party logistics provider" means a person that
7contracts with a prescription drug manufacturer to provide or coordinate
8warehousing, distribution, or other services on behalf of the manufacturer but that
9does not take title to the manufacturer's prescription drug or have general
10responsibility to direct the prescription drug's sale or disposition.
AB1-SSA1,26 11Section 26 . 450.01 (23) (p) of the statutes is created to read:
AB1-SSA1,23,1312 450.01 (23) (p) The services of a 3rd-party logistics provider or out-of-state
133rd-party logistics provider.
AB1-SSA1,27 14Section 27 . 450.02 (1) of the statutes is amended to read:
AB1-SSA1,23,2015 450.02 (1) The department shall keep a record of the proceedings and a register
16of the names and places of practice or business of pharmacies, manufacturers,
17wholesale distributors, 3rd-party logistics providers, out-of-state 3rd-party
18logistics providers,
and other persons licensed under this chapter, and the books,
19registers and records of the department shall be prima facie evidence of the matters
20recorded.
AB1-SSA1,28 21Section 28 . 450.03 (1) (fm) of the statutes is created to read:
AB1-SSA1,23,2522 450.03 (1) (fm) A person who is enrolled at an accredited school of pharmacy
23and whose practice of pharmacy is limited to administering vaccines against
24SARS-CoV-2 under the direct supervision of a person licensed as a pharmacist by
25the board.
AB1-SSA1,29
1Section 29. 450.035 (2g) of the statutes is amended to read:
AB1-SSA1,24,112 450.035 (2g) A person engaged in the practice of pharmacy under s. 450.03 (1)
3(f), (fm), or (g) may not administer a vaccine unless he or she acts under the direct
4supervision of a pharmacist and he or she and the supervising pharmacist have
5successfully completed 12 hours in a course of study and training, approved by the
6Accreditation Council for Pharmacy Education or the board, in vaccination storage,
7protocols, administration technique, emergency procedures, and record keeping and
8the supervising pharmacist has satisfied the requirements specified in sub. (2t). A
9person engaged in the practice of pharmacy under s. 450.03 (1) (f) , (fm), or (g) may
10not administer a vaccine under this subsection to a person who is under the age of
116.
AB1-SSA1,30 12Section 30 . 450.035 (2i) (am) of the statutes is created to read:
AB1-SSA1,24,1513 450.035 (2i) (am) Subject to sub. (2g), a person engaged in the practice of
14pharmacy under s. 450.03 (1) (fm) may administer without a prescription order a
15vaccine against SARS-CoV-2.
AB1-SSA1,31 16Section 31 . 450.035 (3) of the statutes is amended to read:
AB1-SSA1,24,2017 450.035 (3) A pharmacist or a person engaged in the practice of pharmacy
18under s. 450.03 (1) (f), (fm), or (g) who successfully completes a course of study and
19training specified in sub. (1r), (1t), (2), or (2g) shall maintain proof of completion and,
20upon request, provide copies of such proof to the department or the board.
AB1-SSA1,32 21Section 32 . 450.035 (4) of the statutes is amended to read:
AB1-SSA1,25,222 450.035 (4) A pharmacist or person engaged in the practice of pharmacy under
23s. 450.03 (1) (f), (fm), or (g) who administers a vaccine to a person under this section
24shall update, or cause a pharmacy to update, the Wisconsin Immunization Registry

1established by the department of health services within 7 days of administering the
2vaccine.
AB1-SSA1,33 3Section 33 . 450.075 of the statutes is created to read:
AB1-SSA1,25,9 4450.075 Third-party logistics providers; licensure. (1) License allowed.
5A person acting as a 3rd-party logistics provider or an out-of-state 3rd-party
6logistics provider of any drug or device may apply to obtain a license from the board
7under this section. Where operations are conducted at more than one facility, a
8person acting as a 3rd-party logistics provider or out-of-state 3rd-party logistics
9provider may apply to obtain a license from the board for each such facility.
AB1-SSA1,25,12 10(2) Application. An applicant for a license under this section shall submit a
11form provided by the board showing all of the following and swear or affirm the
12truthfulness of each item in the application:
AB1-SSA1,25,1313 (a) The name, business address, and telephone number of the applicant.
AB1-SSA1,25,1414 (b) All trade or business names used by the applicant.
AB1-SSA1,25,1715 (c) Names, addresses, and telephone numbers of contact persons for all
16facilities used by the applicant for the warehousing, distribution, or other services
17on behalf of the manufacturer of prescription drugs.
AB1-SSA1,25,1818 (d) The type of ownership or operation for the applicant's business.
AB1-SSA1,25,2019 (e) If the applicant's 3rd-party logistics provider business is a partnership, the
20name of each partner and the name of the partnership.
AB1-SSA1,25,2321 (f) If the applicant's 3rd-party logistics provider business is a corporation, the
22name of each corporate officer and director, the name of the corporation, and the state
23of incorporation.
AB1-SSA1,25,2524 (g) If the applicant's 3rd-party logistics provider business is a sole
25proprietorship, the name of the sole proprietor and the name of the business entity.
AB1-SSA1,26,2
1(h) A list of all licenses and permits issued to the applicant by any other state
2that authorizes the applicant to warehouse or distribute prescription drugs.
AB1-SSA1,26,33 (i) The name, address, and telephone number of a designated representative.
AB1-SSA1,26,54 (j) For the person identified as the designated representative in par. (i), a
5personal information statement that contains all of the following:
AB1-SSA1,26,66 1. The person's date and place of birth.
AB1-SSA1,26,87 2. The person's place of residence for the 7-year period immediately preceding
8the date of the application.
AB1-SSA1,26,109 3. The person's occupations, positions of employment, and offices held during
10the 7-year period immediately preceding the date of the application.
AB1-SSA1,26,1211 4. The name and addresses for each business, corporation, or other entity listed
12in subd. 3.
AB1-SSA1,26,1613 5. A statement indicating whether the person has been, during the 7-year
14period immediately preceding the date of the application, the subject of any
15proceeding for the revocation of any business or professional license and the
16disposition of the proceeding.
AB1-SSA1,26,2117 6. A statement indicating whether the person has been, during the 7-year
18period immediately preceding the date of the application, enjoined by a court, either
19temporarily or permanently, from possessing, controlling, or distributing any
20prescription drug, and a description of the circumstances surrounding the
21injunction.
AB1-SSA1,27,222 7. A description of any involvement by the person during the past 7 years with
23any business, including investments other than the ownership of stock in a publicly
24traded company or mutual fund, that manufactured, administered, prescribed,

1distributed, or stored pharmaceutical products or drugs, and a list of any lawsuits
2in which such a business was named as a party.
AB1-SSA1,27,83 8. A description of any misdemeanor or felony criminal offense of which the
4person was, as an adult, found guilty, whether adjudication of guilt was withheld or
5the person pleaded guilty or no contest. If the person is appealing a criminal
6conviction, the application shall include a copy of the notice of appeal, and the person
7shall submit a copy of the final disposition of the appeal not more than 15 days after
8a final disposition is reached.
AB1-SSA1,27,109 9. A photograph of the person taken within the 12-month period immediately
10preceding the date of the application.
AB1-SSA1,27,1511 (k) A statement that each facility used by the applicant for 3rd-party logistics
12provider services has been inspected in the 3-year period immediately preceding the
13date of the application by the board, a pharmacy examining board of another state,
14the National Association of Boards of Pharmacy, or another accrediting body
15recognized by the board, with the date of each such inspection.
AB1-SSA1,27,18 16(3) Licensure. The board shall grant a license to an applicant to act as a
173rd-party logistics provider or an out-of-state 3rd-party logistics provider if all of
18the following apply:
AB1-SSA1,27,1919 (a) The applicant pays the fee specified in s. 440.05 (1).
AB1-SSA1,27,2220 (b) The inspections conducted pursuant to sub. (2) (k) satisfy requirements
21adopted by the board for 3rd-party logistics providers or out-of-state 3rd-party
22logistics providers.
AB1-SSA1,27,2423 (c) All of the following apply to each person identified by the applicant as a
24designated representative:
AB1-SSA1,27,2525 1. The person is at least 21 years old.
AB1-SSA1,28,3
12. The person has been employed full time for at least 3 years in a pharmacy
2or with a wholesale prescription drug distributor in a capacity related to the
3dispensing of and distribution of, and record keeping related to, prescription drugs.
AB1-SSA1,28,44 3. The person is employed by the applicant full time in a managerial position.
AB1-SSA1,28,105 4. The person is physically present at the 3rd-party logistics provider's or
6out-of-state 3rd-party logistics provider's facility during regular business hours
7and is involved in and aware of the daily operation of the 3rd-party logistics provider
8or the out-of-state 3rd-party logistics provider. This subdivision does not preclude
9the person from taking authorized sick leave and vacation time or from being absent
10from the facility for other authorized business or personal purposes.
AB1-SSA1,28,1211 5. The person is actively involved in and aware of the daily operation of the
123rd-party logistics provider or the out-of-state 3rd-party logistics provider.
AB1-SSA1,28,1713 6. The person is a designated representative for only one applicant at any given
14time. This subdivision does not apply if more than one 3rd-party logistics provider
15or out-of-state 3rd-party logistics provider is located at the facility and the
163rd-party logistics providers or out-of-state 3rd-party logistics providers located at
17the facility are members of an affiliated group.
AB1-SSA1,28,1918 7. The person has not been convicted of violating any federal, state, or local law
19relating to distribution of a controlled substance.
AB1-SSA1,28,2020 8. The person has not been convicted of a felony.
AB1-SSA1,28,2521 9. The person submits to the department 2 fingerprint cards, each bearing a
22complete set of the applicant's fingerprints. The department of justice shall provide
23for the submission of the fingerprint cards to the federal bureau of investigation for
24purposes of verifying the identity of the person and obtaining the person's criminal
25arrest and conviction record.
AB1-SSA1,29,2
1(d) The applicant satisfies any other requirements established by the board by
2rule.
AB1-SSA1,29,8 3(4) Rules. The board shall promulgate rules implementing this section. The
4rules shall ensure compliance with the federal drug supply chain security act, 21
5USC 360eee
, et seq. The board may not promulgate rules that impose requirements
6more strict than the federal drug supply chain security act, or any regulations passed
7under the federal drug supply chain security act. The board may not promulgate
8rules that require a license under this section.
AB1-SSA1,29,12 9(5) Access to records. Applications for licensure under this section are not
10subject to inspection or copying under s. 19.35, and may not be disclosed to any
11person except as necessary for compliance with and enforcement of the provisions of
12this chapter.
AB1-SSA1,29,17 13(6) Inspections. A 3rd-party logistics provider or an out-of-state 3rd-party
14logistics provider shall allow the board and authorized federal, state, and local law
15enforcement officials to enter and inspect its facilities and delivery vehicles, to audit
16its records and written operating procedures, and to confiscate prescription drugs
17and records to the extent authorized by law, rule, or regulation.
AB1-SSA1,29,22 18(7) Applicability. This section does not apply if the board determines that the
19federal food and drug administration has established a licensing program for
203rd-party logistics providers under 21 USC 360eee-3 and that licensing by this state
21of resident 3rd-party logistics providers is not required for a resident 3rd-party
22logistics provider to provide 3rd-party logistics provider services in another state.
AB1-SSA1,34 23Section 34 . 450.11 (5) (br) 2. d. of the statutes is amended to read:
AB1-SSA1,30,3
1450.11 (5) (br) 2. d. A pharmacist may not extend a prescription order under
2subd. 1. for a particular patient if a prescription order was previously extended under
3subd. 1. for that patient during the applicable period described in subd. 3.
AB1-SSA1,35 4Section 35 . 450.11 (5) (br) 3. of the statutes is renumbered 450.11 (5) (br) 3.
5(intro.) and amended to read:
AB1-SSA1,30,66 450.11 (5) (br) 3. (intro.) This paragraph applies only during as follows:
AB1-SSA1,30,9 7a. During the public health emergency declared on March 12, 2020, by
8executive order 72, and for 30 days after the conclusion of that public health
9emergency. During that time,
AB1-SSA1,30,11 104. While this paragraph applies as specified in subd. 3., it supersedes par. (bm)
11to the extent of any conflict.
AB1-SSA1,36 12Section 36 . 450.11 (5) (br) 3. b. of the statutes is created to read:
AB1-SSA1,30,1413 450.11 (5) (br) 3. b. During the period beginning on the effective date of this
14subd. 3. b. .... [LRB inserts date], and ending on June 30, 2021.
AB1-SSA1,37 15Section 37 . 609.205 (2) (intro.) and (a) of the statutes are amended to read:
AB1-SSA1,30,2116 609.205 (2) (intro.) All of the following apply to a defined network plan or
17preferred provider plan during the state of emergency related to public health
18declared under s. 323.10 on March 12, 2020, by executive order 72, and for the 60 days
19following the date that the state of emergency terminates
until the conclusion of a
20national emergency declared by the U.S. president under 50 USC 1621 in response
21to the 2019 novel coronavirus or June 30, 2021, whichever is earlier
:
AB1-SSA1,31,422 (a) The plan may not require an enrollee to pay, including cost sharing, for a
23service, treatment, or supply provided by a provider that is not a participating
24provider in the plan's network of providers more than the enrollee would pay if the
25service, treatment, or supply is provided by a provider that is a participating

1provider. This subsection applies to any service, treatment, or supply that is related
2to diagnosis or treatment for COVID-19 and to any service, treatment, or supply that
3is provided by a provider that is not a participating provider because a participating
4provider is unavailable due to the public health emergency.
AB1-SSA1,38 5Section 38 . 609.205 (3) (intro.) of the statutes is amended to read:
AB1-SSA1,31,136 609.205 (3) (intro.) During the state of emergency related to public health
7declared under s. 323.10 on March 12, 2020, by executive order 72, and for the 60 days
8following the date that the state of emergency terminates
Until the conclusion of a
9national emergency declared by the U.S. president under 50 USC 1621 in response
10to the 2019 novel coronavirus or June 30, 2021, whichever is earlier
, all of the
11following apply to any health care provider or health care facility that provides a
12service, treatment, or supply to an enrollee of a defined network plan or preferred
13provider plan but is not a participating provider of that plan:
AB1-SSA1,39 14Section 39 . 632.895 (14g) (b) of the statutes is amended to read:
AB1-SSA1,31,2215 632.895 (14g) (b) Before March 13, 2021 Until the conclusion of a national
16emergency declared by the U.S. president under 50 USC 1621 in response to the 2019
17novel coronavirus or June 30, 2021, whichever is earlier
, every disability insurance
18policy, and every self-insured health plan of the state or of a county, city, town,
19village, or school district, that generally covers vaccination and testing for infectious
20diseases shall provide coverage of testing for COVID-19 and vaccination against the
21SARS-CoV-2 coronavirus
without imposing any copayment or coinsurance on the
22individual covered under the policy or plan.
AB1-SSA1,40 23Section 40 . 632.895 (16v) (a) (intro.) of the statutes is amended to read:
AB1-SSA1,32,524 632.895 (16v) (a) (intro.) During the period covered by the state of emergency
25related to public health declared by the governor on March 12, 2020, by executive

1order 72
Until June 30, 2021, an insurer offering a disability insurance policy that
2covers prescription drugs, a self-insured health plan of the state or of a county, city,
3town, village, or school district that covers prescription drugs, or a pharmacy benefit
4manager acting on behalf of a policy or plan may not do any of the following in order
5to maintain coverage of a prescription drug:
AB1-SSA1,41 6Section 41 . 655.0025 of the statutes is created to read:
AB1-SSA1,32,12 7655.0025 Participation during COVID-19 national emergency. Until
8the conclusion of a national emergency declared by the U.S. president under 50 USC
91621
in response to the 2019 novel coronavirus or June 30, 2021, whichever is earlier,
10all of the following apply to a physician or nurse anesthetist for whom this state is
11not a principal place of practice but who is authorized to practice in this state on a
12temporary basis:
AB1-SSA1,32,16 13(1) The physician or nurse anesthetist may fulfill the requirements of s. 655.23
14(3) (a) by filing with the commissioner a certificate of insurance for a policy of health
15care liability insurance issued by an insurer that is authorized in a jurisdiction
16accredited by the National Association of Insurance Commissioners.
AB1-SSA1,32,18 17(2) The physician or nurse anesthetist may elect, in the manner designated by
18the commissioner by rule under s. 655.004, to be subject to this chapter.
Loading...
Loading...